首页 正文

Novel curcumin derivative DMC-GF suppresses glioblastoma growth by targeting MAPK1 and TRIM21 to modulates STAT3/AKT phosphorylation

{{output}}
Glioblastoma multiforme (GBM) remains a therapeutic challenge with a poor prognosis, necessitating novel treatment strategies. This study investigated the anti-tumor efficacy of a novel demethoxycurcumin derivative, DMC-GF, against GBM. Both in vitro assays an... ...